Project Grant R25CA291603
Award Date 8/1/25
Completion Date 7/31/30
Dollars Obligated $221K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
- This federal Cooperative Agreement award is from the National Cancer Institute (NCI), under the 21st Century Cures Act - Beau Biden Cancer Moonshot federal grant program (CFDA 93.353). The $1,594,797 award supports a project to evaluate strategies for scaling up and sustaining tobacco use treatment (TUT) in cancer survivors across a network of 72 clinics. The project aims to adapt and refine implementation strategies, harmonize outcome measures, and establish the feasibility of a multi-stage...
- The federal Project Grant award titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit" is funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $663,554.00 with an award date of August 18, 2025 and an ultimate completion date of July 31, 2030. The grant supports research to explore the use of harm reduction product sampling, such as e-cigarettes, heated tobacco products, and oral...
- This Project Grant award of $226,504 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to understand tobacco use trajectories and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities. The study aims to examine disparities in the use of diverse tobacco products, as well as the underlying mechanisms such as marketing exposure and product perceptions, within these populations. The research...
- This Project Grant award, with a total funding amount of $957,600.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will be used by Drexel University to develop a novel framework for community-directed research approaches that seek to reduce intersectional and intergenerational inequities in commercial tobacco use among Black and Latinx adult sexual and gender minorities in Philadelphia. Key activities...
- This federal Project Grant award of $742,500 from the National Institute on Drug Abuse (NIDA), which is part of the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on a peer recovery coaching intervention to promote tobacco abstinence among individuals with opioid use disorder. The award will fund a 3-year pilot study to adapt a behavioral tobacco use disorder (TUD) intervention called PEERTTS for people with opioid use disorder and TUD, and to train peer recovery...
- This federal Project Grant award of $164,484.00 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports the development and evaluation of smoking cessation messages targeted to adults who smoke nondaily. The project, conducted by the University of Kentucky Research Foundation, aims to create tailored communications that increase knowledge, worry, risk perceptions, motivation, and intentions to quit smoking among this population. The researchers will...
- The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...
- This Project Grant award of $899,273.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The purpose of the award is to support a research project titled "Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients." The research will be conducted by Washington University in St. Louis, with a sub-award to the Vandeventer Place Research Foundation. The project aims to explore...
- This $129,480 Project Grant, awarded on December 1, 2024 by the National Cancer Institute (CFDA 93.398 Cancer Research Manpower), aims to examine tobacco use relapse among cancer survivors. The study will recruit 122 cancer survivors at high risk of relapse from the VCU Massey Cancer Center to complete surveys assessing intrapersonal factors (e.g., cancer worry, negative affect) and interpersonal factors (e.g., social support, social constraint) as predictors of tobacco use relapse. A subset...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 (Trans-NIH Research Support) is supporting a $675,599 study titled "Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale". The primary awardee is Rutgers, The State University of New Jersey, who will collaborate with Columbia University on the project. The study aims to: 1) characterize the implementation and reach of...